fbpx

What do 10 year follow-up data on sleeve gastrectomy tell us about long-term results?

Posted on: 21st Aug, 2018

Among the patients who had type two diabetes before surgery, the vast majority experienced complete remission at year 1, and then as the years passed, diabetes gradually returned in a minority of the patients. But even 10 years after surgery, there was still a persistent 55% reduction in the number of people who were considered to have diabetes, compared to before surgery. Laparoscopic sleeve gastrectomy (LSG) remains the safest, and most effective treatment of type two diabetes among individuals with obesity. That includes treatment with medications, injections, insulin, etc. In the last five years our LSG patient population of more than 1,500 people have enjoyed a mortality rate of 0.0% and a risk of the major complication of leak at 0.0%.  Because the weight loss and diabetes remission rates are equivalent to gastric bypass, but the safety record is better and complications lower, sleeve gastrectomy remains the best treatment for most people with obesity and diabetes.   For people who do develop a recurrence of diabetes or weight regain years later, the sleeve procedure is highly compatible with a simple surgical revision involving the duodenum (SADI procedure) that once again creates remission of diabetes and massive weight loss without an invasive surgery.  ]]>

Similar Recent Posts

  • Bladder & Bowel Leakage Treatment Options – A New Post on Sixty & Me

    • dr-sasse-reno-incontinence-treatment-options

      Dr. Sasse contributes regular articles to Sixty & Me, a wonderful online community of 500,000 women over 60. In his recent post, he included a comprehensive overview of seven treatment options for bladder and bowel leakage. Here’s a short overview of the post, but we encourage you to jump over to Sixty & Me to Read More…

  • Study finds Weight-Loss Surgery Likely Saved Lives of Covid-19 Patients

    • dr-kent-sasse-research-skin-cancer-obesity

      In a recent study from the excellent research team at The Cleveland Clinic, investigators reported the results of obese individuals who acquired COVID-19. They compared two matched groups among a total of 363 COVID-19 patients: one group with obesity and one group with prior morbid obesity but having had weight-loss surgery. The findings were significant. No Read More…

  • Newest Sacral Neuromodulation Device Highly Effective at Two Years

    • dr-kent-sasse-research-skin-cancer-obesity

      The recently released two-year study of 141 patients with urinary incontinence treated with the sacral neuromodulation (SNM) device showed excellent results at the two-year mark. SNM is a twenty-year-old therapy that has been increasingly refined in recent years. The thirty-minute procedure involves placement of a small chip-like device under the skin near a person’s back Read More…

Contact Us with any Questions Regarding your Bariatric Health

It is important that you give us your accurate weight and height, so we can best assist you.

There are Two Ways to Get Started
Actual Patient
Address
Sasse Surgical Associates
75 Pringle Way
Suite 804

Reno, NV 89502
Minimally invasive weight loss surgery experts.info@sassesurgical.com(775) 829-7999
Phone
Office Hours
Monday
7:30 am - 5:00 pm
Tuesday
7:30 am - 5:00 pm
Wednesday
7:30 am - 5:00 pm
Thursday
7:30 am - 5:00 pm
Friday
7:30 am - 3:00 pm
Saturday
Closed
Sunday
Closed